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Abstract
Background: The typical Western diet is not balanced in methyl nutrients that regulate the level of the methyl donor S-
adenosylmethionine (SAM) and its derivative metabolite S-adenosylhomocysteine (SAH), which in turn may control the
activity of certain methyltransferases. Feeding rodents with amino acid defined and methyl-imbalanced diet decreases
hepatic SAM and causes liver cancers. RIZ1 (PRDM2 or KMT8) is a tumor suppressor and functions in transcriptional
repression by methylating histone H3 lysine 9.
Methodology/Principal Findings: Here we show that a methyl-balanced diet conferred additional survival benefits
compared to a tumor-inducing methyl-imbalanced diet only in mice with wild type RIZ1 but not in mice deficient in RIZ1.
While absence of RIZ1 was tumorigenic in mice fed the balanced diet, its presence did not prevent tumor formation in mice
fed the imbalanced diet. Microarray and gene expression analysis showed that, unlike most of its related enzymes, RIZ1 was
upregulated by methyl-balanced diet. Methyl-balanced diet did not fully repress oncogenes such as c-Jun in the absence of
RIZ1. Higher RIZ1 activity was associated with greater H3 lysine 9 methylation in RIZ1 target genes as shown by chromatin
immunoprecipiation analysis.
Conclusions/Significance: The data identify RIZ1 as a critical target of methyl-balanced diet in cancer prevention. The
molecular understanding of dietary carcinogenesis may help people make informed choices on diet, which may greatly
reduce the incidence of cancer.
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Introduction
The typical Western diet is linked to a third of all cancer deaths
in the United States [1]. The diet is rich in meat and low in
vegetables and fruits. It is not balanced in methyl nutrients or low
in folic acid. Dietary nutrients, and their metabolic intermediates
and products, directly influence the activity of many cellular
enzymes. One class of such enzymes is SAM-dependent
methyltransferases, a broad group of enzymes that have one
property in common, the use of S-adenosylmethionine (SAM) as
methyl group donor. The cellular level of SAM depends on dietary
intake of methyl group donors, such as methionine, folic acid,
vitamin B6, B12, and choline. Some methylation reactions are
inhibited by low level SAM or high level of the product inhibitor
S-adenosylhomocysteine (SAH). Methyl imbalanced diet that is
low in folic acid, methionine, or choline is known to lower SAM
level and SAM/SAH ratio.
Feeding rodents with amino acid defined and methyl-imbal-
anced diet decreases hepatic SAM and causes liver cancers [2,3,4].
The molecular mechanisms underlying the relationship between
diet and cancer remain poorly understood. We have previously
proposed that methyl-balanced diet prevents cancer by activating
the histone lysine methyltransferase (KMT) class tumor suppres-
sors such as RIZ1 (PRDM2 or KMT8) [5,6]. The RIZ1 tumor
suppressor functions in transcriptional repression by methylating
histone H3 lysine 9 [7,8,9]. Here, we determined whether RIZ1
may be a critical target of methyl balanced diet in cancer
prevention. We also performed microarray and gene expression
analysis to study the effect of diet on RIZ1 and other genes. The
effect of diet on RIZ1 methylation enzyme activity was analyzed
by chromatin immunoprecipiation assay. The results suggest that
RIZ1 is regulated by diet and may be a critical target of methyl-
balanced diet in cancer prevention.
Results
We compared RIZ1 mutant and wild type mice on a methyl-
balanced diet (diet 1), versus an imbalanced diet lacking
methionine and choline (diet 2). The methyl-imbalanced diet 2
(see Supplementary Table S1) is well known to lower hepatic SAM
and cause liver cancers in rodents [2,3,4]. Thus, this methyl-
imbalanced diet caused liver tumors and decreased survival
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compared with the methyl-balanced diet (Figure 1A). Most of the
dead or moribund animals that were suitable for autopsy analysis
were found to have hepatocarcinomas. In contrast, in the absence
of wild type RIZ1, there was no difference in survival regardless of
diet (Figure 1B). These RIZ1 knockout animals developed mostly
hepatocarcinomas regardless of diet. Therefore, while the
balanced diet 1 conferred additional survival benefits compared
to the imbalanced diet 2 in mice with wild type RIZ1, it failed to
do so in mice deficient in RIZ1.
The data also shows that, consistent with previous work [7],
RIZ1+/+ mice had lower mortality and tumor incidence than
RIZ12/2 mice when fed methyl-balanced diet 1 (Figure 1C).
However, when fed imbalanced diet 2, RIZ1+/+ mice showed
similar mortality as RIZ12/2 mice (Figure 1D). Thus the tumor
suppressor function of RIZ1 is dependent on a methyl-balanced
diet. The similar survival rates of RIZ1-deficient and wild type
animals on diet 2 (Figure 1D) also suggests that the capacity of diet
1 to confer additional survival benefits compared to diet 2 in RIZ1
wild type (Figure 1A) but not in RIZ1-deficient animals (Figure 1B)
is not because of the trivial reason that the RIZ1-deficient animals
may be too sick in general to respond to diet 1.
To determine the effects of diet on RIZ1, we examined RIZ1
gene expression in the liver target tissue using quantitative RT-
PCR and Western blot analysis. RIZ1 mRNA level was
downregulated 4.2 fold after treatment with diet 2 for 2 months
(Supplementary Table S2). The downregulation was not evident at
1 month on diet 2 but became obvious at 2, 4, and 6 months
(Supplementary Table S2). The downregulation of RIZ1 by the
methyl-imbalanced diet was confirmed by western blot analysis
(Figure 2). In contrast to RIZ1, the shorter RIZ2 protein that lacks
the PR/SET domain [10] was not significantly affected by diet.
We also examined other methyltransferases and related
enzymes by quantitative RT-PCR and DNA microarray analysis.
A total of 25 histone methyltransferases were examined, including
at least one enzyme specific for each of the amino acid residues
that are known to be methylated. None of these enzymes, except
RIZ1, was significantly downregulated (.2 fold) at 2 months of
diet 2 treatment (Supplementary Table S2).
Figure 1. Survival of RIZ1 wild type and mutant animals on diet 1 versus diet 2. A. The viability of RIZ1 wild type animals on diet 1 versus
diet 2. B. The viability of RIZ1 mutant animals on diet 1 versus diet 2. C. The viability of RIZ1 wild type and mutant animals on diet 1. D. The viability
of RIZ1 wild type and mutant animals on diet 2. Most of the dead or moribund animals that were suitable for autopsy analysis were found to have
tumors. The graph was drawn with the Prism statistics software program (GraphPad Software) based on the Kaplan-Meyer theory. P values were
calculated by Fisher’s exact test (2 tailed) using the survival rate at ages 20 to 22 months.
doi:10.1371/journal.pone.0003390.g001
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To further determine whether RIZ1 expression is sensitive to
SAM levels, we used the MATA1 knockout mice model [11].
These animals have lower (3 to 4 fold) hepatic SAM and also
develop liver cancers. Quantitative RT-PCR analysis of animals at
4.5–5.5 months of age showed that RIZ1 expression in wild type
livers (n = 6) was 2.0 fold higher than in the MATA1 knockouts
(n = 5, P = 0.03, Student’s t test, 2 tailed), comparable to the fold
reduction for the same aged wild type mice on diet 2
(Supplementary Table S2).
We next examined whether RIZ1 target genes were regulated
by diet. DNA microarray analysis of livers of RIZ1 wild type
animals at 2 months of diet treatment revealed a list of 1636 genes
that were affected by diet by more than 2 fold (Supplementary
Table S3). DNA microarray analysis of livers of RIZ1 knockout
animals identified 97 putative RIZ1 target genes showing more
than 2 fold difference between wild type and knockout
(Supplementary Table S4). Of these, 29 were also present in the
list of genes regulated by diet, indicating a significant enrichment
of RIZ1 target genes in the list of diet-regulated genes (29/97
versus 1636/48000, P,0.0001, Chi squared test, 2 tailed). The
genes of interest that were upregulated by both RIZ1 knockout
and methyl-imbalanced diet include c-Jun, c-Fos, and Ctgf. Some
of these genes might play a direct role in liver cancers (i.e., c-Jun)
[12]. The effect of RIZ1 knockout or diet on the expression of
these genes was confirmed by quantitative RT-PCR analysis
(Table 1). The results suggest that downregulation of RIZ1 by diet
2 was associated with deregulation of RIZ1 target genes.
Since RIZ1 expression was not significantly altered by diet 2 at
1 month treatment (Supplementary Table S2), any expression
changes of the target genes of RIZ1 at 1 month diet treatment may
reflect changes in RIZ1 activity rather than in expression level. We
selected seven RIZ1 target genes and determined their expression
levels at either 1 month or 2 months diet treatment. As shown in
Table 1, six of the seven genes were found upregulated by diet 2 at
1 month diet treatment. The data suggest that diet 2 caused
deregulation of RIZ1 target genes before significantly decreasing
RIZ1 expression levels.
We next used chromatin immunoprecipitation (ChIP) assay to
examine changes in histone methylation on RIZ1 target genes as a
result of decreased RIZ1 activity. We used a RIZ1-specific
antibody ab9710 (Abcam) that does not react with RIZ2 (see
Supplementary Figure S1 for a Western blot of RIZ1 by this
antibody). As shown in Figure 3A, the c-Jun proximal promoter
was bound by RIZ1 and showed higher levels of H3 lysine 9
monomethylation in RIZ1 wild type versus knockout livers. RIZ1
did not bind to the distal region of the c-Jun promoter or the
promoter of Elovl3 gene that was not repressed by RIZ1. At 1
month diet 2 treatment, H3K9me1 of c-Jun promoter was
decreased even though RIZ1 binding was not changed, suggesting
again that RIZ1 activity was decreased even when RIZ1
expression was at normal levels (Figure 3).
We also examined overall DNA methylation changes in
response to methyl-imbalanced diet in DNA from livers of animals
at 15 months of treatment. While we found that diet 2 decreased
overall DNA methylation (Supplementary Figure S2), we did not
find changes in DNA methylation (either hyper or hypo
methylation) in individual random CpG rich regions (Supplemen-
tary Figure S3) using the technique of Not1-Mse1 MS-AFLP
(methylation sensitive amplified fragment length polymorphism)
[13]. By Western blot analysis, we did not find significant changes
(.2 fold) in methylation of H3K9me1, H3K9me2, H3K9me3,
H4K20me1, and H4K20me2 in the liver of animals that were on
diet 2 for six months (data not shown).
Discussion
Since only RIZ1 and 4 small molecule methyltransferases
(GNMT, GAMT, NNMT, and TEMT) were found downregu-
Figure 2. Regulation of RIZ1 protein expression by diet. A.
Whole cell extracts of liver from animals on diet 1 and diet 2 for two
months were analyzed by Western blot analysis using an antibody that
reacts with both RIZ1 and RIZ2 proteins. Western blot using beta-actin
antibody served as loading control. B. Quantification of protein levels
by densitometry analysis. Data are the means6SD of 4 animals per
subgroup. *P= 0.012 (Student’s t-test, 2 tailed).
doi:10.1371/journal.pone.0003390.g002
Table 1. Quantitative RT-PCR analysis of genes that were
upregulated by RIZ1 deficiency or by diet 2 treatment.
Genes KO vs. WT Diet 2 vs. Diet 1
2 months 1 month
Abcc4 2.1 13.1 10.2
Alas1 4.0 2.3 1.3
Ctgf 2.2 2.4 2.3
Fos 2.4 5.0 4.7
Gdf15 2.3 2.7 3.7
Jun 2.0 8.0 2.6
Mthfd1l 1.6 5.1 3.0
Fold changes in liver RNA expression of 7 putative RIZ1 target genes in RIZ1
knockout versus wild type animals were shown. Also shown are fold changes in
liver RNA expression of 7 putative RIZ1-target genes in RIZ1 wild type animals
on diet 2 versus diet 1 after either 1 month or 2 months of diet treatment. Data
represent means of at least 3 animals per subgroup. P,0.05 (Student’s t-test, 2
tailed) for all data set except Alas1 at 1 month diet treatment.
doi:10.1371/journal.pone.0003390.t001
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lated by diet 2 in a non-biased screening using both DNA
microarray and RT-PCR methods (see Supplementary Table S2),
we examined whether these 5 enzymes shared some common
properties that could explain their sensitivity to diet. We found
from the literature Km values for SAM for 3 of the 4 small
molecule methyltransferases and all three turned out to have high
Km value (.49 mM) (see Supplementary Table S5). For the large
number of methyltransferases that were not regulated by diet, we
identified Km values for 7 of them and all 7 have Km values lower
than 10 mM (see Supplementary Table S5). Thus, there is a
significant association between high Km for SAM and downreg-
ulation by diet 2 (P=0.0083, Fisher’s exact test, 2 tailed).
Hepatic SAM concentration is ,60 mM and methyl-imbal-
anced diet typically causes a 1.5 to 3 fold drop in SAM levels
[3,14], which would be still high enough to allow near maximum
activity for most methyltransferases with low Km for SAM but
would significantly inhibit those enzymes with high Km values.
The preferential downregulation by diet 2 of the methyltransfer-
ases with high Km for SAM may reflect a feedback inhibition on
their own gene expression by unliganded or unused enzymes. The
canonical SET domain shared by most KMTs has low Km for
SAM [15]. But RIZ1 may be an exception since its SET domain is
different from others [16,17].
Numerous effects of methyl-imbalanced diet, such as fat
accumulation, protein kinase C activation, abnormal cell turnover,
oxidative stress, low SAM/SAH ratio, DNA hypomethylation, and
uracil incorporation into DNA or mutation, are prevented by a
methyl-balanced diet. In addition, a methyl-imbalanced diet
affects the expression of numerous genes as shown here. Our
observation that deficiency of a single gene may neutralize the
cancer preventive benefit of a methyl-balanced diet shows that at
least one of the numerous effects of such diet may play a rate-
limiting role in the cancer prevention process.
From all these observations it can be postulated that the
molecular pathway of carcinogenesis by methyl-imbalanced diet
may be the following: a methyl-imbalanced diet — chronic low
SAM/SAH ratio in most cells of a diet-responsive target tissue —
inhibition and downregulation of RIZ1 in most cells of the target
tissue — upregulation of prosurvival and progrowth oncogenes
such as c-Jun in most cells of the target tissue — stochastic
accumulative genetic and epigenetic changes in a single cell —
clonal proliferation of the single cell — cancer. In this multi-cell
origin model of cancer initiation [6], inactivation of RIZ1 and
upregulation of some oncogenes such as c-Jun in most cells of a
diet-responsive tissue may not be sufficient to cause clonal
proliferation but may allow a large pool of less than fully normal
cells to be more prone to clonal proliferation in response to
stochastic strong oncogenic mutations in a single cell. In contrast,
fully normal cells may undergo senescence or cell death in
response to oncogenic mutations [18]. Thus, a rate-limiting step in
Figure 3. Regulation of histone methylation on RIZ1 target genes. A. Soluble chromatin was prepared from livers of RIZ1 wild type and
knockout animals. Immunoprecipitation was performed using the indicated antibodies. DNA was amplified using primer sets that cover the proximal
or the distal promoter regions of c-Jun and Elovl3 gene. B. Soluble chromatin was prepared from livers of wild type animals on either diet 1 or diet 2
for 1 month. Immunoprecipitation was performed using the indicated antibodies. DNA was amplified using primer sets that cover the proximal or the
distal promoter regions of c-Jun and Elovl3 gene. One representative data set is shown out of four experiments performed.
doi:10.1371/journal.pone.0003390.g003
RIZ1 in Cancer Prevention
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cancer prevention may be the maintenance of RIZ1 activity in
most cells of a target tissue [6].
Materials and Methods
Animals, diets, and tissues
RIZ1 knockout mice in 129Sv/C57Bl6 background were
crossed to 129Sv mice for 8 generations to produce RIZ1
knockout mice in 99.625% 129Sv background. These RIZ12/2
mice were then crossed with p53+/2 129Sv mice (from Jackson
Laboratory) to generate RIZ1+/2p53+/2 mouse in 129Sv
background. Animals of the following genotypes were maintained
for experimental use: RIZ12/2p53+/2 and RIZ1+/+p53+/2.
The introduction of p53 heterozygous mutation was intended to
shorten the latency of tumor development in the RIZ1 knockout
mice [7]. Male animals of each genotype were randomized into
two groups of ,30 each. Starting at about 4 weeks of age, all
animals were fed with a methyl-balanced and amino acid-defined
diet or diet 1. After on this diet for one week, one group of animals
continued to stay on diet 1 for the remaining period of the
experiment. The other group were fed with methionine and
choline deficient diet or diet 2. The compositions of the diets (see
Supplementary Table S1) were essentially the same as those
commonly used in the field [2,3,4]. Diets were stored at 4uC and
given ad libitum with biweekly replacement. Animal growth was
followed by monthly body weight measurement for upto 15
months. No significant difference in body weight was noted for
different genotypes. Animals on diet 2 showed reduced (15% less
at 15 months of age) body weight compared to animals on diet 1.
This slight effect of diet 2 on body weight was similar to what
others have found [2]. Kaplan-Meyer survival curves were plotted
using the Prism statistics program (GraphPad software). The liver
tissues were fixed for histological analyses or snap frozen in liquid
nitrogen and stored at 280uC until used for biochemical analyses.
Tissues fixed in 10% formalin were routinely processed for
paraffin embedding, sectioned, and stained with hematoxylin and
eosin. For measurements of dietary effects on gene expression and
histone methylation, additional animals were fed diet 1 or 2 for 1
to 6 months before being sacrificed for tissue collection.
Ethical approval for all works on animals was obtained from the
Animal Research Committee of The Burnham Institute for
Medical Research.
Western blotting
Tissues were homoginized in RIPA buffer (150 mM NaCl, 1%
Nonidet P-40, 0.25% Na-deoxycholate, 1 mM EDTA, 50 mM
Tris-HCl, pH 7.4, plus proteinase inhibitors). The whole lysates
were then mixed with SDS gel loading buffer followed by SDS gel
fractionation and western blotting. RIZ antibody was rabbit serum
KG7.1S against RIZ1 aa 245–573 that reacts with both RIZ1 and
RIZ2, as described previously (available from Abcam ab3790)
[19]. For western blot against RIZ1 but not RIZ2, we used the
abcam RIZ1 antibody ab9710. Antibodies for methylated histones
were from Abcam and Upstate.
Quantitative RT-PCR
Total RNAs were extracted from tissues using the MagNa Lyser
Green Beads (Roche) and the RNAmini kit (Qiagen). Quantitative
RT-PCR analyses (SYBR green) were performed using the
Mx3000P QPCR system of Stratagene. All gene specific primers
were confirmed to give a single band of expected size. Cyclophilin
A (PPIA) gene served as a control for RNA amount. This gene was
not regulated by diet or RIZ1 knockout as indicated by microarray
analysis.
DNA microarray analysis
cDNAs synthesized from total RNAs were hybridized with
Sentrix Mouse-6 Expression BeadChip from Illumina containing
48,000 gene arrays. Data were obtained from replicate biological
samples. Data normalization was performed using cubic spline
normalization.
ChIP analysis
Rabbit antibody specific for RIZ1 but not RIZ2 from Abcam
(ab9710) was used for ChIP analysis of RIZ1 binding to target
genes. Antibodies for methylationed histones were from Abcam
(ab9045 for H3K9me1, ab8898 for H3K9me3, ab9051 for
H4K20me1) and Upstate (07-212 for H3K9me2). Liver tissues
(,30 mg per antibody immunoprecipitation) were chopped to
pieces using razor blades and cross linked in 1% formaldehyde at
room temperature for 15 min. Chromatin was fragmented to an
average size of 700 bp using a Misonix XL2020 sonicator. The
ChIP assay kit from Upstate was used. For PCR, we used the
following primer pairs: 59-AAATCTCTGGTTTCCAGGTA-
CAGC-39 (2801 to 2777) and 59- GAGAAAGGGCTGAAT-
GATCTGAGT-39 (2595 to 2571) for c-Jun proximal promoter
region, and 59-GTGTGGGGGTAGAGGAGTGA-39 (24337 to
24317) and 59- AGTGTCACTGGACCCTCACC -39 (24128 to
24108) for c-Jun distal region. For PCR of Elovl3 gene promoter,
we used the primer pairs 59-CCCCATTTTTCTCTCCAACA-39
(2768 to 2748) and 59-CCAAGCTGGACCATAAGGAA-39
(2578 to 2558) for the Elovl3 promoter region, and 59-
CCAGGCTGTCCTGAAACTAATTCT-39 (28325 to 28301)
and 59-CTGTAGACCAGGTGACTGCAAACT-39 (28132 to
28108) for the Elovl3 distal region.
DNA methylation analysis
Genomic DNAs were extracted from tissues using standard
procedures. Analysis of methylation in CpG rich regions by Not1-
Mse1 MS-AFLP method was as described previously [13].
Genomic methyl-cytosine content was assayed by the methylation
enzyme Sss1 method [20].
Supporting Information
Table S1 Composition of the amino acid-defined and methyl-
balanced basal diet (Teklad Product No. TD 99366). This is
referred as Diet 1. The methyl-imbalanced diet or diet 2
formulation ((Teklad Product No. TD 01513) is the same as diet
1 except that it contains 9.0 g/Kg DL-Homocystine and lacks
methionine and choline bitartrate.
Found at: doi:10.1371/journal.pone.0003390.s001 (0.05 MB
DOC)
Table S2 Quantitative RT-PCR and microarray analysis of
some histone methyltransferases and related enzymes. Wild type
male animals were treated with diet 1 or diet 2 (starting from 3–4
weeks of age) for 1, 2, 4, and 6 months before RNA extraction
from livers. Levels of 25 histone methyltransferases and 8 other
related enzymes were determined by either quantitative RT-PCR
or microarray or both, and the ratio (fold change) Diet 1 versus
Diet 2 calculated. Data from quantitative RT-PCR represent
means of at least 3 animals per subgroup. *P,0.05 Diet 1 vs. Diet
2 (Student’s t-test, 2 tailed). Histone methyltransferases that are
not listed here did not show significant expression in the liver as
revealed by DNA microarray analysis. Data from microarray
analysis represent means of 2 animals per subgroup. DNA
microarray analysis revealed downregulation by diet 2 of four
small molecule methyltransferases, GNMT, GAMT, NNMT, and
RIZ1 in Cancer Prevention
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TEMT, which were subsequently confirmed by quantitative RT-
PCR.
Found at: doi:10.1371/journal.pone.0003390.s002 (0.08 MB
DOC)
Table S3 Genes regulated by diet as revealed by DNA
microarray analysis. Wild type mice were fed with either diet 1
or diet 2 for two months before their livers were collected for RNA
extraction. Data represent means of 2 animals per subgroup. Only
genes showing more than 2 fold changes are listed.
Found at: doi:10.1371/journal.pone.0003390.s003 (0.85 MB
XLS)
Table S4 Genes regulated by RIZ1 knockout as revealed by
DNA microarray analysis. The RNAs used for analysis were from
wild type and knockout mice of four months of age on balanced
diet. Data represent means of 2 animals per subgroup. Genes in
bold were also regulated by diet. Only genes showing more than 2
fold changes are listed.
Found at: doi:10.1371/journal.pone.0003390.s004 (0.06 MB
XLS)
Table S5 Methyltransferases with high Km value for SAM were
downregulated by methyl-imbalanced diet. The Km value for
SAM and Ki value for SAH are shown for various methyltrans-
ferases. The ratio (fold changes) Diet 1 vs. Diet 2 in expression
levels of the methyltransferases was calculated from quantitative
RT-PCR. Data represent means of at least 3 animals per subgroup
at 2 months of diet treatment. *P,0.05 Diet 1 vs. Diet 2 (Student’s
t-test, 2 tailed).
Found at: doi:10.1371/journal.pone.0003390.s005 (0.03 MB
DOC)
Figure S1 Western blot analysis confirming recognition of RIZ1
but not RIZ2 by the Abcam RIZ1-specific antibody ab9710. Total
protein extracts of livers from either RIZ1 wild type or knockout
animals were resolved by SDS gel followed by western blot using
RIZ1 antibody ab9710. Equal loading was confirmed by western
blot using beta-actin antibody.
Found at: doi:10.1371/journal.pone.0003390.s006 (0.07 MB
PDF)
Figure S2 DNA hypomethylation in mice fed with diet 2. Total
genomic DNAs were isolated from livers of mice on either diet 1 or
diet 2 for 15 months. The methylation levels of these DNAs were
determined by the Sss1 enzyme assay. Data are the means+SD of
3 animals per subgroup. *P= 0.03 (Student’s t-test, 2 tailed).
Found at: doi:10.1371/journal.pone.0003390.s007 (0.02 MB
PDF)
Figure S3 Analysis of methylation changes in CpG rich regions
of the genome by MS-AFLP. A. Genomic DNA isolated from
MCF7 cells that were either treated or not treated with the
demethylating agent Aza-C were used as a positive control for the
MS-AFLP method. B. The genomic DNAs used for analysis were
from brain (B) and liver (L) tissues of mice on either diet 1 or diet 2
for 15 months.
Found at: doi:10.1371/journal.pone.0003390.s008 (1.49 MB
PDF)
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